Your browser doesn't support javascript.
loading
Generation of antibodies against COVID-19 virus for development of diagnostic tools
Maohua Li; Ronghua Jin; Ya Peng; Cuiyan Wang; Wenlin Ren; Fudong Lv; Sitao Gong; Feng Fang; Qianyun Wang; Jianli Li; Tong Shen; Hunter Sun; Lei Zhou; Yali Cui; Hao Song; Le Sun.
Afiliación
  • Maohua Li; AbMax Biotechnology Co., LTD
  • Ronghua Jin; Beijing You'an Hospital, Capital Medical University
  • Ya Peng; Laboratory of Animal Infectious Diseases, College of Animal Sciences and Veterinary Medicine, Guangxi University
  • Cuiyan Wang; AbMax Biotechnology Co., LTD
  • Wenlin Ren; AbMax Biotechnology Co., LTD
  • Fudong Lv; Beijing You'an Hospital, Capital Medical University
  • Sitao Gong; AbMax Biotechnology Co., LTD
  • Feng Fang; AbMax Biotechnology Co., LTD
  • Qianyun Wang; AbMax Biotechnology Co., LTD
  • Jianli Li; AbMax Biotechnology Co., LTD
  • Tong Shen; AbMax Biotechnology Co., LTD
  • Hunter Sun; AnyGo Technology Co., Ltd
  • Lei Zhou; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences
  • Yali Cui; College of Life Sciences, Northwest University
  • Hao Song; Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences
  • Le Sun; AbMax Biotechnology Co., LTD
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20025999
ABSTRACT
The COVID-19 China coronavirus started in Dec 2019 was challenged by the lack of accurate serological diagnostic tool for this deadly disease to quickly identify and isolate the infected patients. The generation of COVID-19-specific antibodies is essential for such tasks. Here we report that polyclonal and monoclonal antibodies were generated by immunizing animals with synthetic peptides corresponding to different areas of Nucleoprotein (N) of COVID-19. The specificities of the COVID-19 antibodies were assessed by Western Blot analysis against NPs from COVID-19, MERS and SARS. Antibodies were used for immunohistochemistry staining of the tissue sections from COVID-19 infected patient, as a potential diagnostic tool. A Sandwich ELISA kit was quickly assembled for quantitation of the virus/NP of COVID-19 concentrations in the vaccine preparations. Development of POCT is also aggressively undergoing.
Licencia
cc_by_nd
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Idioma: En Año: 2020 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Idioma: En Año: 2020 Tipo del documento: Preprint